#Tag · Bonfire Dinteg Labs

Discussion

#Tag

About
Code of conduct
Privacy
About Bonfire

Researchers have developed and validated an experimental compound, FLAV-27, capable of reversing #cognitive decline in Alzheimer's disease by reprogramming the neuronal epigenome to correct altered gene expression rather than merely clearing amyloid plaques.
#Neuropharmacology #Epigenetics #Neuroscience #sflorg
https://www.sflorg.com/2026/03/pharm03142601.html

Researchers design a pioneering drug capable of reversing cognitive decline in Alzheimer’s disease in animal models

This opens the door to a new category of therapies: epigenetic disease-modifying treatments, which could complement or even replace current strategies

Copy link
Flag this post

Block

Scientific Frontline

@sflorg@mastodon.social · activity timestamp 4 days ago

Researchers design a pioneering drug capable of reversing cognitive decline in Alzheimer’s disease in animal models

This opens the door to a new category of therapies: epigenetic disease-modifying treatments, which could complement or even replace current strategies

Copy link
Flag this post

Block

Bonfire Dinteg Labs

This is a bonfire demo instance for testing purposes. This is not a production site. There are no backups for now. Data, including profiles may be wiped without notice. No service or other guarantees expressed or implied.

Bonfire Dinteg Labs: About · Code of conduct · Privacy ·

Bonfire social · 1.0.0 no JS en

Automatic federation enabled

Explore
About
Code of Conduct

Home Login